Silence Therapeutics Stock (NASDAQ: SLN) stock price, news, charts, stock research, profile.
You can purchase shares of Silence Therapeutics (NASDAQ:SLN) through any online brokerage.
Other companies in Silence Therapeutics’s space includes: Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Humacyte (NASDAQ:HUMA), Replimune Group (NASDAQ:REPL) and Tango Therapeutics (NASDAQ:TNGX).
Silence Therapeutics has a consensus price target of $52.80.
The stock price for Silence Therapeutics (NASDAQ: SLN) is $18.07 last updated September 25, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Silence Therapeutics.
Silence Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Silence Therapeutics.
Silence Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.